788
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Prognostic value of Bcl-2 in two independent populations of estrogen receptor positive breast cancer patients treated with adjuvant endocrine therapy

, , , , , , & show all
Pages 781-789 | Received 10 Oct 2011, Accepted 16 Dec 2012, Published online: 30 Mar 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Christina Bjerre, Ann Knoop, Karsten Bjerre, Mathilde S. Larsen, Katrine L. Henriksen, Maria B. Lyng, Henrik J. Ditzel, Birgitte B. Rasmussen, Nils Brünner, Bent Ejlertsen & Anne-Vibeke Lænkholm. (2013) Association of tissue inhibitor of metalloproteinases-1 and Ki67 in estrogen receptor positive breast cancer. Acta Oncologica 52:1, pages 82-90.
Read now

Articles from other publishers (16)

Hui Guo, Yan Qin Tan, Xiaoming Huang, Shuwei Zhang, Basappa Basappa, Tao Zhu, Vijay Pandey & Peter E. Lobie. (2023) Small molecule inhibition of TFF3 overcomes tamoxifen resistance and enhances taxane efficacy in ER+ mammary carcinoma. Cancer Letters 579, pages 216443.
Crossref
Ioannis A. Voutsadakis. (2023) Breast cancer sub-types display heterogeneity in gene amplification and mRNA expression of the anti-apoptotic members of BCL2 family. Gene 857, pages 147179.
Crossref
Murat Tad & Sezer Kulaçoğlu. (2019) P53, HER2/neu, Bcl-2 and PCNA overexpression in ductal carcinoma in situ lesions of the breast and their role in progression to invasive carcinoma. Ortadoğu Tıp Dergisi 11:4, pages 490-496.
Crossref
Elie Dagher, Jérôme Abadie, Delphine Loussouarn, Dominique Fanuel, Mario Campone & Frédérique Nguyen. (2019) Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational study. BMC Veterinary Research 15:1.
Crossref
Murat Tad & Sezer Kulaçoğlu. (2018) Memenin Duktal Karsinoma in Situ Lezyonları: Histopatolojik özellikler ile p53, HER2/neu, bcl-2 ve PCNA Ekspresyonu arasındaki ilişki. Dicle Tıp Dergisi, pages 265-273.
Crossref
Hitisha K. Patel & Teeru Bihani. (2018) Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment. Pharmacology & Therapeutics 186, pages 1-24.
Crossref
S. Alkner, M.-B. Jensen, B. B. Rasmussen, P.-O. Bendahl, M. Fernö, L. Rydén & H. Mouridsen. (2017) Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98. Breast Cancer Research and Treatment 166:2, pages 481-490.
Crossref
Chunjie Wen, Lanxiang Wu, Lijuan Fu, Xue Zhang & Honghao Zhou. (2016) Berberine enhances the anti-tumor activity of tamoxifen in drug-sensitive MCF-7 and drug-resistant MCF-7/TAM cells. Molecular Medicine Reports 14:3, pages 2250-2256.
Crossref
D Merino, S W Lok, J E Visvader & G J Lindeman. (2015) Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer. Oncogene 35:15, pages 1877-1887.
Crossref
Lin-Ying Chen, Julia Y. S. Tsang, Yun-Bi Ni, Siu-Ki Chan, Kui-Fat Chan, Sheng Zhang & Gary M. Tse. (2015) Bcl2 and Ki67 refine prognostication in luminal breast cancers. Breast Cancer Research and Treatment 149:3, pages 631-643.
Crossref
Anieta M. Sieuwerts, Maria B. Lyng, Marion E. Meijer-van Gelder, Vanja de Weerd, Fred C.G.J. Sweep, John A. Foekens, Paul N. Span, John W.M. Martens & Henrik J. Ditzel. (2014) Evaluation of the ability of adjuvant tamoxifen‐benefit gene signatures to predict outcome of hormone‐naive estrogen receptor‐positive breast cancer patients treated with tamoxifen in the advanced setting. Molecular Oncology 8:8, pages 1679-1689.
Crossref
Vijay Pandey, Zheng-Sheng Wu, Min Zhang, Rui Li, Jian Zhang, Tao Zhu & Peter E Lobie. (2014) Trefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma. Breast Cancer Research 16:5.
Crossref
Rosalind Brigham Penney & Deodutta Roy. (2013) Thioredoxin-mediated redox regulation of resistance to endocrine therapy in breast cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1836:1, pages 60-79.
Crossref
Chao-Yang Xu, Zhi-Nong Jiang, Ying Zhou, Jia-Jia Li & Li-Ming Huang. (2013) Estrogen Receptor α Roles in Breast Cancer Chemoresistance. Asian Pacific Journal of Cancer Prevention 14:7, pages 4049-4052.
Crossref
Maria B. Lyng, Anne-Vibeke Lænkholm, Qihua Tan, Werner Vach, Karina H. Gravgaard, Ann Knoop & Henrik J. Ditzel. (2013) Gene Expression Signatures That Predict Outcome of Tamoxifen-Treated Estrogen Receptor-Positive, High-Risk, Primary Breast Cancer Patients: A DBCG Study. PLoS ONE 8:1, pages e54078.
Crossref
Mohamed K. Al-Sadoon, Mostafa A. Abdel-Maksoud, Danny M. Rabah & Gamal Badr. (2012) Induction of Apoptosis and Growth Arrest in Human Breast Carcinoma Cells by a Snake ( Walterinnesia aegyptia ) Venom Combined With Silica Nanoparticles: Crosstalk Between Bcl2 and Caspase 3 . Cellular Physiology and Biochemistry 30:3, pages 653-665.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.